Slifka M K, Whitmire J K, Ahmed R
Emory Vaccine Center and the Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30307, USA.
Blood. 1997 Sep 1;90(5):2103-8.
Immunizing bone marrow donors prior to bone marrow transplant (BMT) has the potential for adoptively transferring specific immunity against opportunistic pathogens. Studies have shown that long-term antibody production occurs in the bone marrow and that specific humoral immunity may be transferred from donor to recipient following BMT. However, the magnitude and duration of T-cell memory in the bone marrow compartment has not been adequately investigated. In this study, virus-specific CD8+ T-cell responses in the bone marrow were compared with those observed in the spleen of mice acutely infected with lymphocytic choriomeningitis virus (LCMV). During the acute stages of infection, most CD8+ T cells in the spleen and bone marrow showed upregulated surface expression of the activation/memory marker, LFA-1 (LFA-1[hi]). After clearing LCMV infection, the antiviral immune response subsided to homeostatic levels and the ratio of CD8+/LFA-1(hi) to CD8+/LFA-1(lo) T cells in the spleen and bone marrow of LCMV immune mice returned to the value observed in naive mice. Virus-specific ex vivo effector cytotoxic T-lymphocyte (CTL) responses could be identified in both spleen and bone marrow compartments at 8 days postinfection. LCMV-specific CTL precursor (CTLp) frequencies peaked in the bone marrow at 8 days postinfection and averaged one in 200 to one in 650 CD8+ T cells, a frequency similar to that observed in the spleen. After clearing the acute infection, potent LCMV-specific CTL memory responses could be demonstrated in the bone marrow for at least 325 days postinfection, indicating long-term persistence of antiviral T cells at this site. Adoptive transfer of LCMV-immune bone marrow into severe combined immunodeficiency (SCID) mice provided protection against viral challenge, whereas SCID mice that received naive bone marrow became chronically infected upon challenge with LCMV. These results indicate that after acute viral infection, virus-specific memory T cells can be found in the bone marrow compartment and are maintained for an extended period, and when adoptively transferred into an immunodeficient host, they are capable of conferring protection against chronic viral infection.
在骨髓移植(BMT)前对骨髓供体进行免疫接种,有可能过继性转移针对机会性病原体的特异性免疫。研究表明,骨髓中会发生长期抗体产生,并且在BMT后特异性体液免疫可能从供体转移至受体。然而,骨髓区室中T细胞记忆的强度和持续时间尚未得到充分研究。在本研究中,将骨髓中病毒特异性CD8+T细胞反应与急性感染淋巴细胞性脉络丛脑膜炎病毒(LCMV)的小鼠脾脏中观察到的反应进行了比较。在感染的急性期,脾脏和骨髓中的大多数CD8+T细胞显示出活化/记忆标志物LFA-1(LFA-1[hi])的表面表达上调。清除LCMV感染后,抗病毒免疫反应消退至稳态水平,LCMV免疫小鼠脾脏和骨髓中CD8+/LFA-1(hi)与CD8+/LFA-1(lo)T细胞的比例恢复到未感染小鼠中观察到的值。在感染后8天,在脾脏和骨髓区室中均可鉴定出病毒特异性体外效应细胞毒性T淋巴细胞(CTL)反应。LCMV特异性CTL前体(CTLp)频率在感染后8天在骨髓中达到峰值,平均每200至650个CD8+T细胞中有1个,该频率与在脾脏中观察到的频率相似。清除急性感染后,在感染后至少325天可在骨髓中证明有强大的LCMV特异性CTL记忆反应,表明抗病毒T细胞在该部位长期持续存在。将LCMV免疫的骨髓过继性转移至严重联合免疫缺陷(SCID)小鼠中可提供针对病毒攻击的保护,而接受未感染骨髓的SCID小鼠在受到LCMV攻击后会发生慢性感染。这些结果表明,急性病毒感染后,病毒特异性记忆T细胞可在骨髓区室中发现并长期维持,当过继性转移至免疫缺陷宿主时,它们能够提供针对慢性病毒感染的保护。